A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : TNFi

Search Conditions:
Search Keyword : TNFi
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: TNFi
Appearance Frequency: 467 time(s)
Long forms: 14

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
tumor necrosis factor inhibitors
(303 times)
Rheumatology
(170 times)
RA (147 times)
PsA (45 times)
AS (42 times)
2009 Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors.
TNF inhibitors
(93 times)
Rheumatology
(51 times)
RA (42 times)
TNF (13 times)
AS (11 times)
1998 An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha.
tumor necrosis factor-alpha inhibitors
(35 times)
Rheumatology
(13 times)
RA (17 times)
DMARDs (4 times)
MTX (4 times)
2006 Access to tumour necrosis factor inhibitors for rheumatoid arthritis treatment under the Australian Pharmaceutical Benefits Scheme: are we on target?
TNF-alpha inhibitor
(25 times)
Rheumatology
(13 times)
RA (11 times)
AS (5 times)
ABA (2 times)
2012 Certolizumab pegol for the treatment of rheumatoid arthritis.
tumour necrosis factor
(2 times)
Cell Biology
(1 time)
cAMP (1 time)
COPD (1 time)
Hu-PBL (1 time)
2000 Human pancreatic islets transfected to produce an inhibitor of TNF are protected against destruction by human leukocytes.
alternative-mechanism-TNF-inhibitor
(1 time)
Orthopedics
(1 time)
bDMARD (1 time)
RA (1 time)
RCT (1 time)
2014 The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug.
anti-tumor necrosis factor alpha therapy
(1 time)
Musculoskeletal Diseases
(1 time)
AS (1 time)
HR (1 time)
PsA (1 time)
2019 Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor alpha Therapies in Patients With Spondyloarthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry.
anti-tumour necrosis factor
(1 time)
Drug Therapy
(1 time)
IBD (1 time)
SSIs (1 time)
VDZ (1 time)
2018 Risk of post-operative surgical site infections after vedolizumab vs anti-tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease.
non-TNF inhibitor
(1 time)
Therapeutics
(1 time)
RA (1 time)
2017 Abatacept Monotherapy Versus Abatacept Plus Methotrexate for Treatment-Refractory Rheumatoid Arthritis.
10  TNF-inhibiting antibodies
(1 time)
Immune System Diseases
(1 time)
aCCP (1 time)
FcgammaR (1 time)
PBMCs (1 time)
2018 Smoking Is Associated With Low Levels of Soluble PD-L1 in Rheumatoid Arthritis.
11  TNF-inhibiting therapy
(1 time)
Pharmacology
(1 time)
ADA (1 time)
IBD (1 time)
IFX (1 time)
2019 Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases.
12  tumor necrosis factor alpha
(1 time)
Rheumatology
(1 time)
cDMARDs (1 time)
DAS28 (1 time)
ETA (1 time)
2019 Synovial inflammation analyzed by 3-T magnetic resonance imaging in etanercept-treated patients with rheumatoid arthritis indicates persistent disease activity despite of clinical remission: A pilot study.
13  tumor necrosis factor alpha blockers
(1 time)
Rheumatology
(1 time)
ASAS (1 time)
IFX (1 time)
MTX (1 time)
2017 TNFalpha blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis.
14  tumor necrosis factor inhibitor treatment
(1 time)
Rheumatic Diseases
(1 time)
HAQ-DI (1 time)
RF (1 time)
2014 Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor.